Comparison of Chemotherapy Regiments between Cisplatin Etoposide and Cisplatin-Docetaxel on 2-Year and Progression-Free Survival in Late-Stage Non-Small Cell Lung Cancer Patients
Introduction. Chemotherapy is one of therapy choices for the advanced Non-Small Cell Lung Cancer (NSCLC). The success in therapy is measured with the 1-year survival, 2-year survival and the Progression Free Survival (PFS). The success is influenced by many factors: resistant to the citostatic, dosa...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Indonésio |
| Pubblicazione: |
Department of Internal Medicine, Faculty of Medicine Universitas Indonesia
2016-06-01
|
| Serie: | Jurnal Penyakit Dalam Indonesia |
| Soggetti: | |
| Accesso online: | http://jurnalpenyakitdalam.ui.ac.id/index.php/jpdi/article/view/11/11 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|